Skip to main content
Premium Trial:

Request an Annual Quote

BioSystem, ProZyme Team on Glycan Sample Prep

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Madison, Wis.-based BioSystem Development and Hayward, Calif.-based ProZyme today announced that they are collaborating on a new sample preparation workflow for glycan sample preparation that combines their respective technologies.

The firm said that the first product will combine ProZyme's enzymatic N-deglycosylation, labeling, and cleanup chemistry with BioSystem Development's AssayMap high-throughput micro-chromatography platform. They added that the resulting platform provides rapid, quantitative N-glycan sample preparation fully enables for any scale of automation.

According to the partners, conventional glycan analysis methods are laborious and expensive and take up to three days or more to perform. They said that their GlykoScreen Rapid Glycosylation Sample Preparation System can process hundreds of samples in three hours or less.

"We believe that the products of this partnership will have a profound impact on advancing the field of glycobiology and look forward to leading this initiative," ProZyme President Jo Wegstein said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more